SCHEMBL2128339

SCHEMBL2128339

CC(C)([C]=O)CC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11568044 0.78
SCHEMBL269536 0.75
SCHEMBL270059 0.73
SCHEMBL15332723 0.73
SCHEMBL732717 0.72
SCHEMBL3966449 0.72
SCHEMBL9332469 0.71
SCHEMBL8379166 0.71
SCHEMBL1031418 0.71
SCHEMBL666675 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104725628-A Single functional branched polyethylene glycol containing degradable radical, preparation method and biorelevant substance of single functional branched polyethylene glycol XIAMEN SINOPEG BIOTECH CO LTD 2015-06-24 CN claimed
CN-104530415-A Hetero-functionalized Y-type polyethylene glycol derivative, preparation method and biologically related substance thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
CN-104530413-A Biologically related substances modified by multifunctional H-type polyethylene glycol derivative XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
CN-104530417-A Multifunctional H-type polyethylene glycol derivative and preparation method thereof XIAMEN SINOPEG BIOTECH INC 2015-04-22 CN claimed
EP-2231163-A1 COMPOUNDS AND THERAPEUTIC USE THEREOF Myriad Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009073818-A1 COMPOUNDS AND THERAPEUTIC USE THEREOF MYRIAD GENETICS, INC. (US) 2009-06-11 WO claimed
WO-2008115281-A2 COMPOUNDS FOR TREATING VIRAL INFECTIONS MYRIAD GENETICS, INC. (US) 2008-09-25 WO claimed
WO-1989004672-A1 DERIVATIVES OF LINCOSAMINIDE ANTIBIOTICS THE UPJOHN COMPANY (US) 1989-06-01 WO claimed
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2022-05-10 US disclosed
US-10660969-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2020-05-26 US disclosed
CN-106967213-B Eight-arm polyethylene glycol, preparation method, functionalized derivative and modified biologically-relevant substance 厦门赛诺邦格生物科技股份有限公司 2019-11-05 CN disclosed
US-10434182-B2 Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2019-10-08 US disclosed
EP-3184171-B1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2019-03-20 EP disclosed
US-10144752-B2 Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-04 US disclosed
WO-1999045025-A1 ACYLATED BETULIN AND DIHYDROBETULIN DERIVATIVES, PREPARATION THEREOF AND USE THEREOF THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 1999-09-10 WO disclosed
EP-0857018-A1 BETULINIC ACID DERIVATIVES AND USES THEREFOR UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 1998-08-12 EP disclosed
US-5679828-A VIRICIDES BIOTECH RESEARCH LABS, INC. (US) 1997-10-21 US disclosed
WO-1996039033-A1 BETULINIC ACID DERIVATIVES AND USES THEREFOR THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 1996-12-12 WO disclosed
WO-1989004672-A1 DERIVATIVES OF LINCOSAMINIDE ANTIBIOTICS THE UPJOHN COMPANY (US) 1989-06-01 WO disclosed
US-4346173-A CULTURE PRODUCT OF CERTAIN FUNGI, YEASTS, OR BACTERIA TOYO JOZO KABUSHIKI KAISHA (JP) 1982-08-24 US disclosed